Navigation Links
Hyaluron Contract Manufacturing Named a 2007 Economic Impact Award Finalist
Date:9/10/2007

HCM recognized by Massachusetts Alliance for Economic Development on the

basis of its strong contribution to Massachusetts economy

BURLINGTON, Mass., Sept. 10 /PRNewswire/ -- Hyaluron Contract Manufacturing (HCM), a leading provider of aseptic manufacturing services to companies in the pharmaceutical and biotechnology industries, announced today that it has been selected as a finalist for the 2007 Team Massachusetts Economic Impact Award. HCM is one of five companies from the greater Boston area that is being considered for this award based on its strong contribution to the Massachusetts economy since January 1, 2006.

"We are extremely pleased to be among the finalists for this award," stated Shawn Kinney, President of HCM. "To be considered along with some of the other finalists as well as past winners is quite an honor for us."

Since January of 2006, HCM has experienced significant growth, making it one of the fastest growing biotech manufacturers in the Commonwealth. In that time, HCM has invested over 2.25 million in facility expansion and has created nearly forty new jobs bringing its current headcount to eighty-five. In October of 2006, the company applied for a patent on its unique Bubble-free filling(TM) technology designed to reduce or eliminate the bubble inside a prefilled syringe.

HCM's future plans include the expansion of its current facility by at least 6,000 square feet and the addition of several new jobs, bringing the total number of employees to 100 by the end of 2007.

In its fourth year, the Team Massachusetts Economic Impact Award recognizes companies from across the Commonwealth for their outstanding contribution to the Massachusetts economy based on job and facility expansion as well as product launch and community involvement. Past winners include Boston Scientific, Bayer Diagnostics, and Wyeth Biopharmaceuticals.

About HCM:

Hyaluron Contract Manufacturing (HCM) is a leader in aseptic contract manufacturing of filled liquid parenterals and medical devices. Since 1999, HCM has been offering its customers-from newly established firms to large- scale commercial enterprises-innovative and unique solutions to all their aseptic formulation/fill needs. At the core of HCM's business is a commitment to quality, regulatory compliance and on-time delivery. HCM is located in Burlington MA. For further information, visit http://www.hyaluron.com.

Hyaluron Contract Manufacturing, Inc.

99 South Bedford Street

Burlington, MA 01803

Contact: Claudio Tracanna

Office Phone 781-270-7900 x 114

Cell Phone: 781-443-2850

Email ctracanna@hyaluron.com


'/>"/>
SOURCE Hyaluron Contract Manufacturing, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Small Tree Communications awarded $2.85M defense contract
2. Research consortium aims to bring security and defense contracts to Wisconsin
3. Johnson Controls unit lands contract for plug-in hybrid battery
4. Johnson Controls partnership wins new contract
5. Defense contract helps Plexus gain record profits
6. Orbitec will use $25 million Air Force contract to make small launch vehicle
7. WHIE receives state eHealth Initiative contract
8. State defensive on new Oracle contract
9. Fisher Biosciences contracts with Madison-based GenTel BioSurfaces
10. School districts contract with Lawson for new data processing software
11. Doyle says new contracts saving state more than $16 million annually
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... ... 27, 2016 , ... Cambridge Semantics, the leading provider of Smart ... it has been named to The Silicon Review’s “20 Fastest Growing Big Data Companies ... Semantics serves the needs of end users facing some of the most complex data ...
(Date:4/27/2016)... ... ... The Pittcon Organizing Committee is pleased to announce that Charles “Chuck” Gardner was ... since 1987. Since then, he has served in a number of key leadership positions ... the program and exposition committees. In his professional career, Dr. Gardner is the director ...
(Date:4/27/2016)... , April 27, 2016 ... (CSE: NSK) (OTCPink: NSKQB) ( Frankfurt ... an ihre Pressemitteilung vom 13. August 2015 die ... ihre Finanzen um zusätzliche 200.000.000 Einheiten auf 400.000.000 ... Dollar zu bringen. Davon wurden 157.900.000 Einheiten mit ...
(Date:4/27/2016)... ... April 27, 2016 , ... The Board of Directors of ... John Tilton as Chief Commercial Officer.  Mr. Tilton joined Biohaven from Alexion Pharmaceuticals, ... leaders responsible for the commercialization of multiple orphan drug indications. Mr. Tilton ...
Breaking Biology Technology:
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a provider ... MegaMatcher Automated Biometric Identification System (ABIS) , ... multi-biometric projects. MegaMatcher ABIS can process multiple complex ... any combination of fingerprint, face or iris biometrics. ... SDK and MegaMatcher Accelerator , which ...
(Date:4/28/2016)... SAN FRANCISCO and BANGALORE, India ... part of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... service provider, today announced a global partnership that ... convenient way to use mobile banking and payment services. ... Mobility is a key innovation area for financial services, but ...
(Date:4/28/2016)... , April 28, 2016 First quarter 2016: ... up 966% compared with the first quarter of 2015 ... SEK 589.1 M (loss: 18.8) and the operating margin was 40% ... 0.32) Cash flow from operations was SEK 249.9 M ... revenue guidance is unchanged, SEK 7,000-8,500 M. The operating ...
Breaking Biology News(10 mins):